Over the past few decades, neuroimaging has become a ubiquitous tool in basic research
and clinical studies of the human brain. However, no reference standards currently exist to …

Tau pathology is a hallmark of Alzheimer's disease (AD) but also occurs in normal cognitive
aging. Using the tau PET agent 18 F-AV-1451, we examined retention patterns in cognitively …

Alzheimer’s disease (AD) is characterized by the spread of tau pathology throughout the
cerebral cortex. This spreading pattern was thought to be fairly consistent across individuals, …

… W-score map for each patient at W < −1, and to allow for comparison between diagnostic
groups we generated frequency maps to show the proportion of patients with suprathreshold W-…

Independent evidence associates β-amyloid pathology with both non-rapid eye movement (NREM)
sleep disruption and memory impairment in older adults. However, whether the …

Amyloid-β, a hallmark of Alzheimer’s disease, begins accumulating up to two decades before
the onset of dementia, and can be detected in vivo applying amyloid-β positron emission …

Tau is a hallmark pathology of Alzheimer’s disease, and animal models have suggested that
tau spreads from cell to cell through neuronal connections, facilitated by β-amyloid (Aβ). We …

Alzheimer's disease (AD) can present with distinct clinical variants. Identifying the earliest
neurodegenerative changes associated with each variant has implications for early diagnosis, …

Regulation of gene expression drives protein interactions that govern synaptic wiring and
neuronal activity. The resulting coordinated activity among neuronal populations supports …

Recruitment of extra neural resources may allow people to maintain normal cognition despite
amyloid-β (Aβ) plaques. Previous fMRI studies have reported such hyperactivation, but it is …